DOYLESTOWN, PA -- (MARKET WIRE) -- October 10, 2006 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced that the United States Patent and Trademark Office has issued U.S. Patent 6,998,273 relating to an innovative QuantRx device that enables collection of oral fluids in a lateral flow device.
